SCHEMBL5044710

SCHEMBL5044710

BrCc1onc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.41
GPR3 P46089 1/20 0.36
PTGS2 P35354 2/20 0.33
IDO1 P14902 1/20 0.33
ALDH1A1 P00352 6/20 0.33
HPGD P15428 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C19 P33261 1/20 0.32
KDM4E B2RXH2 3/20 0.31
MAOA P21397 2/20 0.31
HSD17B10 Q99714 2/20 0.31
MAOB P27338 2/20 0.31
GLA P06280 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRA2A P08913 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
CHRM1 P11229 1/20 0.31
NQO2 P16083 1/20 0.31
DRD1 P21728 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11919171 0.79 PTGS1 (0.46) ELANEGPR3PTGS2IDO1ALDH1A1
SCHEMBL7002086 0.79 LOXL2 (0.42) ELANEGPR3IDO1ALDH1A1HPGD
SCHEMBL8772908 0.76 ALDH1A1 (0.37) GPR3PTGS2IDO1ALDH1A1HPGD
SCHEMBL8772757 0.75 ALDH1A1 (0.37) ELANEGPR3IDO1ALDH1A1HPGD
SCHEMBL1027461 0.73 SMN1; SMN2 (0.43) PTGS2ALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL3229873 0.73 LMNA (0.40) GPR3PTGS2ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL2493164 0.73 PARP1 (0.43) ELANEALDH1A1HPGDSMN1; SMN2CYP1A2
SCHEMBL7155004 0.72 ALDH1A1 (0.40) ELANEALDH1A1SMN1; SMN2KDM4EHSD17B10
SCHEMBL5298071 0.72 MAOB (0.39) GPR3ALDH1A1HPGDSMN1; SMN2MAOA
Hydrochloric Acid SCHEMBL5697360 0.72 SMN1; SMN2 (0.42) PTGS2ALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492803-B1 NEW ANALOGS OF NITROBENZYLTHIOINOSINE GRUENENTHAL GMBH (DE) 2008-06-11 EP disclosed
US-7358235-B2 Analogs of nitrobenzylthioinosine GRUENENTHAL GMBH (DE) 2008-04-15 US disclosed
US-20050096293-A1 Analogs of nitrobenzylthioinosine GRUENENTHAL GMBH (DE) 2005-05-05 US disclosed
EP-1373229-A4 PROCESS FOR THE PREPARATION OF 1,2-BENZISOXAZOLE-3-ACETIC ACID TEVA PHARMA (IL) 2005-05-04 EP disclosed
EP-1492803-A1 NEW ANALOGS OF NITROBENZYLTHIOINOSINE Grünenthal GmbH (DE) 2005-01-05 EP disclosed
EP-1373229-A1 PROCESS FOR THE PREPARATION OF 1,2-BENZISOXAZOLE-3-ACETIC ACID TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-01-02 EP disclosed
WO-2003084975-A1 NEW ANALOGS OF NITROBENZYLTHIOINOSINE Grünenthal GmbH (DE) 2003-10-16 WO disclosed
EP-1352910-A1 New analogs of nitrobenzylthioinosine Grünenthal GmbH (DE) 2003-10-15 EP disclosed
WO-2002070495-A1 PROCESS FOR THE PREPARATION OF 1,2-BENZISOXAZOLE-3-ACETIC ACID TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2002-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096293-A1 Analogs of nitrobenzylthioinosine NUDT1, TYMP, NNMT ELANE 1178/4885GPR3 3338/4885PTGS2 676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.